Flexible Subscriptions to Match your Budget and Timeline See Plans and Pricing

Serving leading biopharmaceutical companies globally:

Johnson and Johnson
Boehringer Ingelheim
Express Scripts

Last Updated: December 4, 2021

DrugPatentWatch Database Preview

ELIXOPHYLLIN SR Drug Patent Profile

Email this page to a colleague

« Back to Dashboard

When do Elixophyllin Sr patents expire, and when can generic versions of Elixophyllin Sr launch?

Elixophyllin Sr is a drug marketed by Forest Labs and is included in one NDA.

The generic ingredient in ELIXOPHYLLIN SR is theophylline. There are thirty-six drug master file entries for this compound. Fourteen suppliers are listed for this compound. Additional details are available on the theophylline profile page.

DrugPatentWatch® Litigation and Generic Entry Outlook for Elixophyllin Sr

A generic version of ELIXOPHYLLIN SR was approved as theophylline by RHODES PHARMS on September 1st, 1982.

  Free Forever Trial

Drug patent expirations by year for ELIXOPHYLLIN SR
Recent Clinical Trials for ELIXOPHYLLIN SR

Identify potential brand extensions & 505(b)(2) entrants

Vanderbilt University Medical CenterPhase 2

See all ELIXOPHYLLIN SR clinical trials

US Patents and Regulatory Information for ELIXOPHYLLIN SR

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Forest Labs ELIXOPHYLLIN SR theophylline CAPSULE, EXTENDED RELEASE;ORAL 086826-001 Jan 29, 1985 DISCN No No ⤷  Free Forever Trial ⤷  Free Forever Trial ⤷  Free Forever Trial
Forest Labs ELIXOPHYLLIN SR theophylline CAPSULE, EXTENDED RELEASE;ORAL 086826-002 Jan 29, 1985 DISCN No No ⤷  Free Forever Trial ⤷  Free Forever Trial ⤷  Free Forever Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Johnson and Johnson
Express Scripts

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.